179 related articles for article (PubMed ID: 28414812)
1. Deficiency of superoxide dismutase promotes cerebral vascular hypertrophy and vascular dysfunction in hyperhomocysteinemia.
Dayal S; Baumbach GL; Arning E; Bottiglieri T; Faraci FM; Lentz SR
PLoS One; 2017; 12(4):e0175732. PubMed ID: 28414812
[TBL] [Abstract][Full Text] [Related]
2. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice.
Dayal S; Arning E; Bottiglieri T; Böger RH; Sigmund CD; Faraci FM; Lentz SR
Stroke; 2004 Aug; 35(8):1957-62. PubMed ID: 15178827
[TBL] [Abstract][Full Text] [Related]
3. Structure of cerebral arterioles in cystathionine beta-synthase-deficient mice.
Baumbach GL; Sigmund CD; Bottiglieri T; Lentz SR
Circ Res; 2002 Nov; 91(10):931-7. PubMed ID: 12433838
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.
Rodionov RN; Dayoub H; Lynch CM; Wilson KM; Stevens JW; Murry DJ; Kimoto M; Arning E; Bottiglieri T; Cooke JP; Baumbach GL; Faraci FM; Lentz SR
Circ Res; 2010 Feb; 106(3):551-8. PubMed ID: 20019334
[TBL] [Abstract][Full Text] [Related]
5. Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.
Dayal S; Blokhin IO; Erger RA; Jensen M; Arning E; Stevens JW; Bottiglieri T; Faraci FM; Lentz SR
PLoS One; 2014; 9(9):e107734. PubMed ID: 25226386
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase.
Baumbach GL; Didion SP; Faraci FM
Stroke; 2006 Jul; 37(7):1850-5. PubMed ID: 16763183
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
[TBL] [Abstract][Full Text] [Related]
8. Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice.
Devlin AM; Arning E; Bottiglieri T; Faraci FM; Rozen R; Lentz SR
Blood; 2004 Apr; 103(7):2624-9. PubMed ID: 14630804
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction.
Dayal S; Brown KL; Weydert CJ; Oberley LW; Arning E; Bottiglieri T; Faraci FM; Lentz SR
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1996-2002. PubMed ID: 12482825
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
Hwang SY; Siow YL; Au-Yeung KK; House J; O K
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
[TBL] [Abstract][Full Text] [Related]
11. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
Lentz SR; Erger RA; Dayal S; Maeda N; Malinow MR; Heistad DD; Faraci FM
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H970-5. PubMed ID: 10993757
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis.
Dayal S; Gu SX; Hutchins RD; Wilson KM; Wang Y; Fu X; Lentz SR
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1798-804. PubMed ID: 26069236
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
[TBL] [Abstract][Full Text] [Related]
14. Murine models of hyperhomocysteinemia and their vascular phenotypes.
Dayal S; Lentz SR
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1596-605. PubMed ID: 18556571
[TBL] [Abstract][Full Text] [Related]
15. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.
Dayal S; Lentz SR
Antioxid Redox Signal; 2007 Nov; 9(11):1899-909. PubMed ID: 17822370
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.
Jindal A; Rajagopal S; Winter L; Miller JW; Jacobsen DW; Brigman J; Allan AM; Paul S; Poddar R
Neurobiol Dis; 2019 Jul; 127():287-302. PubMed ID: 30885791
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
[TBL] [Abstract][Full Text] [Related]
18. Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice.
Wilson KM; McCaw RB; Leo L; Arning E; Lhoták S; Bottiglieri T; Austin RC; Lentz SR
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):233-40. PubMed ID: 17082485
[TBL] [Abstract][Full Text] [Related]
19. Effects of local reduction in pressure on distensibility and composition of cerebral arterioles.
Baumbach GL; Siems JE; Heistad DD
Circ Res; 1991 Feb; 68(2):338-51. PubMed ID: 1991342
[TBL] [Abstract][Full Text] [Related]
20. Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
Pal Singh A; Kaur T; SinghDahiya R; Singh N; Singh Bedi PM
J Cardiovasc Pharmacol; 2010 Jul; 56(1):53-9. PubMed ID: 20351560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
